Sidley has advised Rigel Pharmaceuticals. Ropes & Gray has advised Pfizer. Rigel Pharmaceuticals, Inc. has entered into an exclusive global license agreement with Arvinas, Inc. and...
Rigel Pharmaceuticals Secures Global License for VEPPANU from Arvinas and Pfizer in $320 Million Deal
HealthCare Royalty Monetizes Royalties on Modeyso Sales
Sidley has advised HealthCare Royalty on the transaction. HealthCare Royalty has entered into a royalty monetization agreement with the Advisory Group representing the former Oncoceutics, Inc....
Sensei Biotherapeutics Acquires Faeth Therapeutics and Raises US$200 Million in Private Placement
Sidley has advised Sensei Biotherapeutics on the deal. Sensei Biotherapeutics, Inc. has completed the acquisition of Faeth Therapeutics and undertaken a private placement expected to generate...
Sensei Biotherapeutics Acquires Faeth Therapeutics
Sidley has advised Sensei Biotherapeutic on the transaction. Cooley has advised Faeth Therapeutics. Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a Nasdaq-listed clinical-stage biotechnology company, has acquired Faeth...
Immunovant Raises $550 Million in Common Stock Offering
Sidley Austin LLP has advised Immunovant, Inc. Latham & Watkins LLP has advised the underwriter. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company focused on developing...
Sagard Healthcare Partners’ $250 Million Non-Dilutive Financings to Nuvation Bio
Cooley represented Nuvation Bio in the transaction, and Sidley Austin represented Sagard Healthcare Partners. Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the...
Verona Pharma’s $650 Million Financing Round
Sidley Austin represented OMERS Life Sciences in the transaction, while Latham & Watkins advised Verona Pharma and Sullivan & Cromwell represented Oaktree Capital Management, L.P. Verona...
Sagard Healthcare’s $200 Million Royalty Purchase Agreement with MannKind Corporation
Sidley Austin represented Sagard Healthcare in the transaction, and Cooley represented MannKind Corporation. Sagard Healthcare (Sagard) announced it entered into a royalty purchase agreement, under which...
Praxis Precision Medicines’ $264 Milion Collaboration and License Agreement with Tenacia Biotechnology
Sidley Austin represented Praxis Precision Medicines, Inc. in the transaction, and Ropes & Gray advised Tenacia. Praxis Precision Medicines, Inc. (NASDAQ: PRAX) announced it has entered...